Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Gregory Granrud"'
Autor:
David Dunbar, Dent R. Underwood, Michael Peterson, Pierce J. Vatterot, Ann Hayden, Denise Carlson, Stuart W. Adler, Spencer H. Kubo, Gregory Granrud, Marjorie Webb, Thomas H. Johnson, Alan J. Bank
Publikováno v:
Journal of Cardiac Failure. 15:S61
Publikováno v:
Clinical Pharmacology and Therapeutics. 42:201-209
Moricizine, 15 mg/kg, was given to 10 patients with frequent ventricular ectopic depolarizations, eight of whom had previously been treated unsuccessfully with antiarrhythmic drugs. A single-blind inpatient study was followed by therapy for up to 6 m
Publikováno v:
The American Journal of Cardiology. 60:1299-1305
The accuracy of 2 commercial 24-hour electrocardiogram analyzers was tested for quantitation of ventricular premature complexes (VPCs). Scanner 1 was the Cardiodata Systems Mark III and scanner 2 was the Avionics Trendsetter DCG VII. Twenty four-hour
Publikováno v:
Journal of the American College of Cardiology. 11(4):843-850
Ten patients were treated with oral indecainide for frequent ventricular ectopic depolarizations during a short-term, dose-ranging, single blind inpatient trial followed by open label long-term therapy for 2 years. During dose ranging, patients recei
Autor:
Gregory Granrud, Donald A. Berry, Patricia Sharkey, Morrison Hodges, Jeananne Krejci, David M. Salerno, Teresa Larson, M. S. Darryl Erlien
Publikováno v:
Clinical Pharmacology and Therapeutics. 40:101-107
We compared side effects with flecainide trough levels and ECG intervals among 43 patients who received flecainide for up to 34 months. Flecainide plasma levels were higher when associated with cardiovascular side effects (mean 1063 ng/ml; range 296
Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent
Autor:
Gregory Granrud, J Krejci, Richard W. Asinger, Morrison Hodges, G J Conard, Frank L. Mikell, J M Haugland
Publikováno v:
Circulation. 65:879-885
Flecainide acetate, a new antiarrhythmic agent, was given orally to 11 hospitalized patients with chronic high-frequency ventricular ectopic depolarizations. Drug effectiveness was evaluated with a dose-ranging single-blind protocol, which included p
Publikováno v:
The American Journal of Cardiology. 53:B66-B71
In this multicenter trial, the efficacy and safety of flecainide, a new antiarrhythmic agent, were compared with those of quinidine, a standard antiarrhythmic agent in the United States. A randomized, parallel, placebo-controlled design was used. Fle
Publikováno v:
The American journal of cardiology. 61(10)
Publikováno v:
The American journal of cardiology. 53(1)
The effectiveness of oral propafenone was evaluated for the treatment of ventricular premature complexes (VPCs) in 12 patients, using a single-blind, dose-ranging trial followed by a double-blind comparison with placebo, and then an open-label, long-
Publikováno v:
The American journal of cardiology. 54(9)
The effectiveness of oral propafenone in treating ventricular premature complexes (VPCs) was assessed with a single-blind dose-ranging trial followed by a double-blind, randomized, crossover comparison of propafenone and placebo. Patients subsequentl